Replimune Group, Inc. current report, 07 September 2022

Replimune Group, Inc. — Form 8-K Summary

Business context and reporting period

Replimune Group, Inc. filed this Form 8-K regarding its annual meeting of stockholders held on September 7, 2022. The filing was signed and submitted on September 8, 2022. The company is a biotechnology company headquartered in Woburn, Massachusetts, with common stock traded on Nasdaq under the symbol REPL.

Meeting results and key metrics

Stockholders voted on the election of four Class I directors and the ratification of PricewaterhouseCoopers LLP as the company’s independent registered public accounting firm for the fiscal year ending March 31, 2023.

Director nomineeVotes forVotes withheldBroker non-votes
Philip Astley-Sparke31,308,9025,731,8147,702,397
Kapil Dhingra20,779,41416,261,3027,702,397
Joseph Slattery30,750,1186,290,5987,702,397
Christy Oliger35,395,0021,645,7147,702,397

All four nominees were elected to serve as Class I directors until the 2025 annual meeting and until their successors are elected and qualified.

Auditor ratificationVotes
For44,739,639
Against2,370
Abstaining1,104

PricewaterhouseCoopers LLP’s appointment was ratified.

Financial performance and material changes

This filing does not provide revenue, profit or loss, cash flow, margins, debt, liquidity, operating guidance, or other financial performance metrics. It does not report a material change versus a prior comparable period.

Outlook, risks, contingencies, and unusual items

The filing contains no new management outlook, risk disclosures, contingencies, or unusual financial items. It identifies the fiscal year ending March 31, 2023, for purposes of the auditor appointment.

Investor verification items

  • Verify the elected Class I director slate and each nominee’s voting totals, including the substantial broker non-vote count.
  • Review the company’s definitive proxy statement filed July 27, 2022 for nominee backgrounds and the detailed proposals.
  • Confirm that PricewaterhouseCoopers LLP remains the independent registered public accounting firm for the fiscal year ending March 31, 2023.
  • Consult the company’s periodic reports for financial condition, cash runway, operating results, and forward-looking guidance, which are not included in this 8-K.